Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 6, 2024; 12(19): 3845-3853
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3845
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3845
Figure 1 Immunohistochemical staining for stromal cell derived factor-1 in livers.
Stromal cell derived factor-1 (SDF-1) distribution was extended to bile ductule and hepatic progenitor cells. A: Strongly positive immunostaining in hepatitis B virus-related acute-on-chronic liver failure (ACLF) patients; B: Moderately positive immunostaining in chronic hepatitis B patients; C: Weakly positive immunostaining in healthy controls; D: Comparison of the SDF-1 average absorbance between ACLF group and other groups. A-C: 200 ×. SDF-1: Stromal cell derived factor-1; ACLF: Acute-on-chronic liver failure; CHB: Chronic hepatitis B.
- Citation: Zhang L, Wang JY, Zhao CY, Shen C, Chen MR, Tian ZY. Prognostic role of the stromal cell derived factor-1 in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2024; 12(19): 3845-3853
- URL: https://www.wjgnet.com/2307-8960/full/v12/i19/3845.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i19.3845